Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Japanese Journal of Cancer Research : Gann
|
July 28, 2001
Enhancement of in vivo antitumor activity of a novel antimitotic 1-phenylpropenone derivative, AM-132, by tumor necrosis factor-alpha or interleukin-6
Y Tatsumi, H Arioka, S Ikeda, et al.
International Archives of Allergy and Immunology
|
June 27, 2000
Induction of apoptosis in bronchial eosinophils: beneficial or harmful?
N Yamashita, M Tajima, J Nakano, et al.
Bone Marrow Transplantation
|
March 7, 1998
Electroencephalogram abnormality and high-dose busulfan in conditioning regimens for stem cell transplantation
R Kobayashi, N Watanabe, A Iguchi, et al.
Anticancer Research
|
November 1, 1996
Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines
K Nishio, T Ishida, H Arioka, et al.
The American Journal of Medicine
|
December 29, 1995
Phorbol ester and okadaic acid-resistant cells: the crossroads of signal transduction and drug resistance
N Saijo, K Nishio, Y Takeda, et al.
Cancer Research
|
February 15, 1996
Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells
M Fukuda, K Nishio, F Kanzawa, et al.
Therapeutic Drug Monitoring
|
June 1, 1995
Efficient sampling strategies for forecasting pharmacokinetic parameters of irinotecan (CPT-11): implication for area under the concentration-time curve monitoring
H Nakashima, R Lieberman, A Karato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1993
Phase I study of CPT-11 and etoposide in patients with refractory solid tumors
A Karato, Y Sasaki, T Shinkai, et al.
Japanese Journal of Cancer Research : Gann
|
September 1, 1994
CPT-11: population pharmacokinetic model and estimation of pharmacokinetics using the Bayesian method in patients with lung cancer
N Yamamoto, T Tamura, A Karato, et al.
International Journal of Cancer
|
September 25, 1997
Circumvention of glutathione-mediated mitomycin C resistance by a novel mitomycin C analogue, KW-2149
T Ishida, K Nishio, H Kurokawa, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Japanese Journal of Cancer Research : Gann
|
July 28, 2001
Enhancement of in vivo antitumor activity of a novel antimitotic 1-phenylpropenone derivative, AM-132, by tumor necrosis factor-alpha or interleukin-6
Y Tatsumi, H Arioka, S Ikeda, et al.
International Archives of Allergy and Immunology
|
June 27, 2000
Induction of apoptosis in bronchial eosinophils: beneficial or harmful?
N Yamashita, M Tajima, J Nakano, et al.
Bone Marrow Transplantation
|
March 7, 1998
Electroencephalogram abnormality and high-dose busulfan in conditioning regimens for stem cell transplantation
R Kobayashi, N Watanabe, A Iguchi, et al.
Anticancer Research
|
November 1, 1996
Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines
K Nishio, T Ishida, H Arioka, et al.
The American Journal of Medicine
|
December 29, 1995
Phorbol ester and okadaic acid-resistant cells: the crossroads of signal transduction and drug resistance
N Saijo, K Nishio, Y Takeda, et al.
Cancer Research
|
February 15, 1996
Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells
M Fukuda, K Nishio, F Kanzawa, et al.
Therapeutic Drug Monitoring
|
June 1, 1995
Efficient sampling strategies for forecasting pharmacokinetic parameters of irinotecan (CPT-11): implication for area under the concentration-time curve monitoring
H Nakashima, R Lieberman, A Karato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1993
Phase I study of CPT-11 and etoposide in patients with refractory solid tumors
A Karato, Y Sasaki, T Shinkai, et al.
Japanese Journal of Cancer Research : Gann
|
September 1, 1994
CPT-11: population pharmacokinetic model and estimation of pharmacokinetics using the Bayesian method in patients with lung cancer
N Yamamoto, T Tamura, A Karato, et al.
International Journal of Cancer
|
September 25, 1997
Circumvention of glutathione-mediated mitomycin C resistance by a novel mitomycin C analogue, KW-2149
T Ishida, K Nishio, H Kurokawa, et al.
Page
of 6